Wealth Science Advisors’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713K Buy
4,868
+4,242
+678% +$769K 0.32% 49
2026
Q1
$122K Buy
+626
New +$102K 0.07% 83

Other funds holding ORCL

Wealth Science Advisors's ORCL Position: Q2 2026 in Review

Wealth Science Advisors increased its Oracle (ORCL) stake by 678% in Q2 2026, buying an estimated $769K and bringing the position to 4,868 shares worth $713K. The position accounts for 0.32% of the portfolio, ranked #49.

Wealth Science Advisors first reported a position in ORCL in Q1 2026 and has held it in 2 quarters since. 2,296 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Wealth Science Advisors held 4,868 shares of Oracle worth $713K as of Q2 2026.
  • Wealth Science Advisors bought 4,242 Oracle shares in Q2 2026, an estimated $769K.
  • Oracle made up 0.32% of Wealth Science Advisors's portfolio in Q2 2026, its #49 holding.
  • Wealth Science Advisors first reported a position in Oracle in Q1 2026 and has held it in 2 quarters since.
  • 2,296 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.